S. ŞAHİN Et Al. , "The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy," ACTA DIABETOLOGICA , vol.47, no.4, pp.325-330, 2010
ŞAHİN, S. Et Al. 2010. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. ACTA DIABETOLOGICA , vol.47, no.4 , 325-330.
ŞAHİN, S., ÇETİNKALP, Ş., ÖZGEN, A. G., Saygili, F., & YILMAZ, C., (2010). The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. ACTA DIABETOLOGICA , vol.47, no.4, 325-330.
ŞAHİN, SERAP Et Al. "The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy," ACTA DIABETOLOGICA , vol.47, no.4, 325-330, 2010
ŞAHİN, SERAP B. Et Al. "The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy." ACTA DIABETOLOGICA , vol.47, no.4, pp.325-330, 2010
ŞAHİN, S. Et Al. (2010) . "The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy." ACTA DIABETOLOGICA , vol.47, no.4, pp.325-330.
@article{article, author={SERAP BAYDUR ŞAHİN Et Al. }, title={The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy}, journal={ACTA DIABETOLOGICA}, year=2010, pages={325-330} }